NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis $63.90 +0.76 (+1.20%) (As of 11:08 AM ET) Add Compare Share Share Today's Range$63.20▼$64.0050-Day Range$55.28▼$65.1652-Week Range$25.11▼$66.04Volume41,941 shsAverage Volume546,233 shsMarket Capitalization$4.72 billionP/E Ratio213.00Dividend YieldN/APrice Target$65.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get RadNet alerts: Email Address RadNet MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside2.5% Upside$65.50 Price TargetShort InterestHealthy4.05% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment1.32Based on 3 Articles This WeekInsider TradingSelling Shares$6.12 M Sold Last QuarterProj. Earnings Growth6.90%From $0.58 to $0.62 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.06 out of 5 starsMedical Sector345th out of 924 stocksMedical Laboratories Industry11th out of 18 stocks 1.4 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 3 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.05% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in RadNet has recently decreased by 2.92%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 3.0 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for RadNet this week, compared to 4 articles on an average week.Search Interest5 people have searched for RDNT on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,121,516.00 in company stock.Percentage Held by InsidersOnly 5.12% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 6.90% in the coming year, from $0.58 to $0.62 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is 213.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 145.08.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is 213.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 138.68.Price to Book Value per Share RatioRadNet has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. About RadNet Stock (NASDAQ:RDNT)RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesAugust 22 at 12:40 AM | markets.businessinsider.comTruist Financial Sticks to Its Buy Rating for Radnet (RDNT)August 17, 2024 | finance.yahoo.comRadNet's (NASDAQ:RDNT) Promising Earnings May Rest On Soft FoundationsAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.August 12, 2024 | msn.comJim Cramer on RadNet, Inc. (RDNT): “Quite a Good Story”August 11, 2024 | uk.finance.yahoo.comRadNet, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowAugust 9, 2024 | seekingalpha.comRadNet, Inc. (RDNT) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | markets.businessinsider.comBarclays Reaffirms Their Hold Rating on Radnet (RDNT)August 9, 2024 | benzinga.comCracking The Code: Understanding Analyst Reviews For RadNetAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.August 9, 2024 | msn.comRadNet, Inc. (NASDAQ:RDNT) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | msn.comRadNet Non-GAAP EPS of $0.16 misses by $0.01, revenue of $459.72M beats by $21.19MAugust 7, 2024 | msn.comRadNet Non-GAAP EPS of $0.16 misses by $0.01, revenue of $459.7M beats by $21.17MAugust 7, 2024 | globenewswire.comRadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance RangesAugust 7, 2024 | markets.businessinsider.comRadNet earnings: here's what to expectJuly 20, 2024 | msn.comRadNet, Inc. (RDNT): Is This Profitable Stock a Strong Buy Now?July 16, 2024 | globenewswire.comRadNet, Inc. Announces Date of its Second Quarter 2024 Financial Results Conference CallJune 20, 2024 | globenewswire.comMaryland Passes Legislation Supported by RadNet to Expand Access to Breast and Lung ScreeningJune 11, 2024 | globenewswire.comRadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12thSee More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today8/22/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees10,288Year Founded1980Price Target and Rating Average Stock Price Target$65.50 High Stock Price Target$75.00 Low Stock Price Target$57.00 Potential Upside/Downside+3.7%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.30 Trailing P/E Ratio210.47 Forward P/E Ratio108.86 P/E GrowthN/ANet Income$3.04 million Net Margins1.28% Pretax Margin3.35% Return on Equity5.05% Return on Assets1.57% Debt Debt-to-Equity Ratio0.76 Current Ratio1.86 Quick Ratio1.86 Sales & Book Value Annual Sales$1.71 billion Price / Sales2.72 Cash Flow$3.62 per share Price / Cash Flow17.42 Book Value$11.79 per share Price / Book5.36Miscellaneous Outstanding Shares73,880,000Free Float70,097,000Market Cap$4.66 billion OptionableOptionable Beta1.75 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 78)Chairman, President & CEO Comp: $5.56MMr. Mark D. Stolper (Age 53)Executive VP & CFO Comp: $1.13MMr. Mital Patel (Age 38)Executive VP of Financial Planning & Analysis and Chief Administrative Officer Comp: $1.15MMr. Norman R. Hames (Age 68)President & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 63)President & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 60)Senior VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 68)Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. A. Gregory Sorensen M.D. (Age 62)Executive VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Senior Vice President of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 59)Executive VP, Chief Legal Officer & Corporate Secretary More ExecutivesKey CompetitorsGenetronNASDAQ:GTHQuest DiagnosticsNYSE:DGXNateraNASDAQ:NTRAExact SciencesNASDAQ:EXASGuardant HealthNASDAQ:GHView All CompetitorsInsiders & InstitutionsCreative PlanningBought 7,662 shares on 8/16/2024Ownership: 0.010%Algert Global LLCBought 6,311 shares on 8/16/2024Ownership: 0.009%The Manufacturers Life Insurance Company Bought 4,074 shares on 8/15/2024Ownership: 0.051%AQR Capital Management LLCBought 160 shares on 8/15/2024Ownership: 0.007%Mackenzie Financial CorpBought 3,708 shares on 8/15/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions RDNT Stock Analysis - Frequently Asked Questions How have RDNT shares performed this year? RadNet's stock was trading at $34.77 at the beginning of 2024. Since then, RDNT stock has increased by 83.8% and is now trading at $63.90. View the best growth stocks for 2024 here. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Wednesday, August, 7th. The medical research company reported $0.16 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by $0.01. The company's revenue for the quarter was up 13.9% on a year-over-year basis. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are RadNet's major shareholders? Top institutional investors of RadNet include Dimensional Fund Advisors LP (2.37%), Principal Financial Group Inc. (1.88%), Hood River Capital Management LLC (1.52%) and Allspring Global Investments Holdings LLC (1.37%). Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, David L Swartz, Lawrence L Levitt, Mark Stolper, Michael N Murdock, David Jeffrey Katz, Ruth Louisa Villigerwilson, Christine Nayoma Gordon and Gregory E Spurlock. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA) and Rigel Pharmaceuticals (RIGL). This page (NASDAQ:RDNT) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredMillionaire Investor Warns: “Brace for Apple Collapse”Apple stock has quadrupled over the past five years. But now even Warren Buffett is pulling the plug. The O...Stansberry Research | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
